Sylvia Dulan
YOU?
Author Swipe
View article: Developing and Monitoring a Standard-of-Care Chimeric Antigen Receptor (CAR) T Cell Clinical Quality and Regulatory Program
Developing and Monitoring a Standard-of-Care Chimeric Antigen Receptor (CAR) T Cell Clinical Quality and Regulatory Program Open
As the world of cellular therapy expands to include immune effector cell (IEC) products such as commercial chimeric antigen receptor (CAR) T cells, quality management (QM) professionals are faced with creating either new IEC stand-alone pr…
View article: Improving Quality Manager (QM) Workload Management in Order to Increase Their Resiliency and Effectiveness in Contributing to Program Success
Improving Quality Manager (QM) Workload Management in Order to Increase Their Resiliency and Effectiveness in Contributing to Program Success Open
BackgroundThe QM's capacity to be resilient during change is a critical skillset. Since 2017, the ASBMT Administrative Directors SIG Quality Working Group and the FACT Quality Management Committee have collaborated to identify opportunitie…
View article: Improving Quality Manager (QM) Resiliency with Open Communication and Trust between the QM and Program and Organizational Leaders
Improving Quality Manager (QM) Resiliency with Open Communication and Trust between the QM and Program and Organizational Leaders Open
BackgroundThe QM role in the field of transplantation and cellular therapies is specialized. QMs may be at risk for stress and burnout, which results in low resiliency/less ability to recharge during change. Since 2017, the ASBMT Administr…